SCHEMBL4434628

SCHEMBL4434628

COc1ccc(C(C(C)=O)c2ccc(C(F)(F)F)cc2)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.51
AKR1C2 P52895 3/20 0.51
MEN1 O00255 1/20 0.45
ALOX15 P16050 1/20 0.45
MAPK1 P28482 1/20 0.45
KMT2A Q03164 1/20 0.45
PPARA Q07869 4/20 0.44
PPARD Q03181 3/20 0.44
ACHE P22303 1/20 0.43
MAPT P10636 1/20 0.43
PDE2A O00408 2/20 0.43
MMP1 P03956 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HPGD P15428 1/20 0.41
CASR P41180 2/20 0.41
PPARG P37231 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4436028 0.91 AKR1C3 (0.49) AKR1C3AKR1C2MEN1ALOX15MAPK1
SCHEMBL4432351 0.91 AKR1C3 (0.49) AKR1C3AKR1C2MEN1ALOX15MAPK1
SCHEMBL4432979 0.88 AKR1C3 (0.51) AKR1C3AKR1C2MAPT
SCHEMBL4430480 0.88 AKR1C3 (0.48) AKR1C3AKR1C2MEN1KMT2AMAPT
SCHEMBL4431032 0.83 PDE4A (0.45) AKR1C3AKR1C2MEN1KMT2AMAPT
SCHEMBL4430282 0.83 PDE10A (0.46) AKR1C3AKR1C2MEN1ALOX15MAPK1
SCHEMBL16973606 0.82 TDP1 (0.51) MEN1KMT2AACHEMAPT
SCHEMBL4432347 0.82 ALDH1A1 (0.50) KMT2APPARAPPARDACHEMAPT
SCHEMBL4432350 0.80 AKR1C3 (0.45) AKR1C3AKR1C2CASR
SCHEMBL4436353 0.80 AKR1C3 (0.40) AKR1C3AKR1C2PDE2ACYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed